PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.85%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
31.09%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
17.55%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-1.09%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
11.80%
R&D change of 11.80% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.64%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
18.77%
Similar total costs growth to CRWV's 18.28%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
-1.49%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
16.27%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-1.71%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
18.99%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
0.12%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
8.82%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
18.26%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
-0.49%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
18.71%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
18.04%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
-0.68%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
14.29%
EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
14.29%
Diluted EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
3.28%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
3.28%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.